NCT01635114View on ClinicalTrials.gov

Effect of resVida on Liver Fat Content

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

September 30, 2015

Conditions
Elevated Liver Fat Content and Insulin Resistance
Interventions
DIETARY_SUPPLEMENT

resveratrol

150 mg resVida per day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo for 12 weeks

Trial Locations (1)

72076

University Hospital Tuebingen, Tübingen

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

University Hospital Tuebingen

OTHER

NCT01635114 - Effect of resVida on Liver Fat Content | Biotech Hunter | Biotech Hunter